Adults with a mental illness experienced weight loss and glycemic benefits with use of a GLP-1 without worsening of mental ...

These drugs, which have been found to help with weight loss, have taken the country by storm. As demand for these medicines ...

A new study has found GLP-1s may reduce the risk of developing obesity-related cancers by 41% compared to bariatric surgery — a benefit researchers believe could be tied to the drugs’ ability to ...

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

"Protein has been shown to boost GLP-1 levels which helps appetite control. Good options for snacks include boiled eggs, ...

A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to ...

And since GLP-1s come with side effects including fatigue, digestive difficulties, and loss of muscle, products to address ...

U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers ...

For everything that was wrong about WeightWatchers, once upon a time it did something right. It tapped into the power of ...

Less than 3% of all people in the U.S. who are eligible for injectable weight loss drugs get a prescription for it, a new ...

Point32Health, the owner of Harvard Pilgrim Health Care and Tufts Health Plan, will dramatically change how and when it pays for Zepbound— the insurer’ s preferred GLP-1 weight-loss drug— when used to ...

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...